4Accepted Aug 28, 6:05 PM ET
Fulgent Genetics (FLGT) CSO Gao Hanlin Sells 939 Shares
Accepted (ET)
6:05 PM
Aug 28, 2026
Filed
Aug 28, 2026
Documents
1
Size
5.5 KB
Summary
Fulgent Genetics (FLGT) CSO Gao Hanlin Sells 939 Shares
What Happened Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), sold 939 shares in an open-market transaction on 2026-08-27 at a weighted-average price of $19.91, generating proceeds of about $18,691. The filing indicates the sale was to satisfy tax-withholding obligations tied to restricted stock units granted on February 26, 2024.
Key Details
- Transaction date: 2026-08-27; Form 4 filed: 2026-08-28 (appears timely).
- Sale type/code: Open-market sale (S).
- Shares sold: 939; weighted-average price: $19.91; total proceeds ≈ $18,691.
- Price range: transactions occurred at $19.83 to $20.00; reported price is the weighted average (footnote F2).
- Reason: Shares were sold to satisfy tax withholding on RSU vesting from the Feb 26, 2024 grant (footnote F1).
- Shares owned after the transaction: not provided in the supplied filing details.
Context This sale was executed as tax-withholding for vested RSUs (a common, non-speculative reason insiders sell). Such covers-for-taxes sales typically reflect administrative needs rather than a directional view on the stock.